Applicant, as named in the Orange Book

Ultragenyx Pharm Inc

Next listed expiry: Dojolvi on 14 Nov 2034. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Dojolvi triheptanoin	triheptanoin	213687	14 Nov 2034	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.